Drugs / Fumaria
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02671162 Comparator | Jul → Oct 2015 | end stage renal failure | Shiraz University of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fumaria | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02671162 ↗ |
| Route | Oral | “It is hypothesized that oral Fumaria parviflora L.” NCT02671162 ↗ |